Biosensors names Evercore Asia as adviser for Citic takeover offer

Published Fri, Nov 20, 2015 · 01:57 AM

THE independent directors of Biosensors International Group has appointed Evercore Asia (Singapore) to provide independent financial advice on a takeover offer by a unit of Citic Group.

Citic Private Equity Funds Management Co is offering 84 Singapore cents per share to privatise Biosensors, a maker of coronary stents and other medical devices. The offer price was at a 24 per cent premium to Citic's pre-deal price of about 68 Singapore cents.

Biosensors stock traded at 80 Singapore cents as at 9.45am on Friday.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes

Companies & Markets

P&G raises annual core profit forecast on resilient demand, price hikes
American Express beats profit estimates on strong spending by wealthy customers
Sheng Siong shareholders press for details on capital allocation, M&A opportunities
Wilmar appoints former minister George Yeo as independent non-executive director
UOB Kay Hian says ‘disadvantageous’ to reveal details of key management’s remuneration
Deutsche Bank has cut dozens in Asia private banking overhaul

Purchase this article

Companies & Markets

Companies & Markets

Biosensors names Evercore Asia as adviser for Citic takeover offer

Companies & Markets

P&G raises annual core profit forecast on resilient demand, price hikes

American Express beats profit estimates on strong spending by wealthy customers

Sheng Siong shareholders press for details on capital allocation, M&A opportunities

Wilmar appoints former minister George Yeo as independent non-executive director

UOB Kay Hian says ‘disadvantageous’ to reveal details of key management’s remuneration

Deutsche Bank has cut dozens in Asia private banking overhaul

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

SECTIONS

LIFESTYLE

Follow BT